AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 19

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.00 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020047AOD-9604SWBSWB-2504-F7630VendorInvestigate2025-Q399.323.05—Buyer-sourced0PASS
AX-2025-019865BPC-157HJHJ-2503-M6159Kestrel2025-Q399.936.02—Buyer-sourced1MARGINAL
AX-2025-019412IGF-1 LR3HYBHYB-2507-Y7485Medutest2025-Q399.134.5596.0Buyer-sourced0PASS
AX-2025-019266GHRP-6AMBAMB-2508-T5301Janoshik2025-Q399.806.26—Laboratory-retained0PASS
AX-2025-020829PT-141 (Bremelanotide)CPCCPC-2502-X2309Medutest2025-Q397.784.9391.1Buyer-sourced0FAIL
AX-2025-020609BPC-157SSASSA-2505-J7334Nordanalyt2025-Q398.663.2792.9Buyer-sourced1MARGINAL
AX-2025-020342CJC-1295 (no DAC)MKMMKM-2504-K3480Janoshik2025-Q398.044.1291.2Buyer-sourced0PASS
AX-2025-019910PEG-MGFHJHJ-2507-S5943Medutest2025-Q398.366.95—Buyer-sourced1FAIL
AX-2025-019869SemaglutideHJHJ-2507-E6156Janoshik2025-Q399.585.4296.7Buyer-sourced0PASS
AX-2025-019837SemaglutideHomopeptideHOMO-2506-M5731Medutest2025-Q397.985.88—Buyer-sourced1MARGINAL
AX-2025-019398CJC-1295 (no DAC)HYBHYB-2504-N7248Nordanalyt2025-Q399.274.17106.6Buyer-sourced0PASS
AX-2025-019254CJC-1295 (no DAC)AMBAMB-2507-S5238PeptideMeter2025-Q399.555.8791.5Buyer-sourced0PASS
AX-2025-020665TirzepatideSGNSGN-2506-J8349PeptideMeter2025-Q397.651.9999.4Buyer-sourced1MARGINAL
AX-2025-0201035-Amino-1MQSWBSWB-2507-E8786PeptideMeter2025-Q399.616.08—Buyer-sourced1FAIL
AX-2025-019396CJC-1295 (no DAC)HYBHYB-2504-N7248Janoshik2025-Q399.214.65100.4Buyer-sourced0PASS
AX-2025-019258GHRP-6AMBAMB-2508-T5301Janoshik2025-Q399.645.91101.4Buyer-sourced0PASS
AX-2025-020521Humanin (HNG)SSASSA-2508-P6927Medutest2025-Q398.944.38—Buyer-sourced0PASS
AX-2025-020344CJC-1295 (no DAC)MKMMKM-2504-K3480Medutest2025-Q398.764.9689.1Buyer-sourced1MARGINAL
AX-2025-020118SemaglutideERPERP-2508-S8293Nordanalyt2025-Q399.382.96—Buyer-sourced1MARGINAL
AX-2025-019842SemaglutideHomopeptideHOMO-2506-M5731Janoshik2025-Q397.606.12—Buyer-sourced1MARGINAL
AX-2025-019259GHRP-6AMBAMB-2508-T5301Nordanalyt2025-Q399.646.43106.7Buyer-sourced0PASS
AX-2025-018950RetatrutideASYASY-{CAT}-1860Janoshik2025-Q397.955.6197.7Laboratory-retained0PASS
AX-2025-018647MK-677 (Ibutamoren mesylate)QSCQSC-2507-F5673PeptideMeter2025-Q399.794.29—Buyer-sourced1FAIL
AX-2025-018458TB-500WWBWWB-2504-F3053Janoshik2025-Q399.315.5696.5Buyer-sourced0PASS
AX-2025-020410LiraglutideMKMMKM-2508-P4928Janoshik2025-Q398.546.54101.6Supplier-supplied2FAIL
AX-2025-020157IpamorelinERPERP-2502-S9437Medutest2025-Q399.053.24101.9Buyer-sourced0PASS
AX-2025-020049AOD-9604SWBSWB-2504-F7630Janoshik2025-Q399.373.3999.4Buyer-sourced0PASS
AX-2025-019766RetatrutideHomopeptideHOMO-2508-U3892Nordanalyt2025-Q398.676.12—Buyer-sourced0PASS
AX-2025-018867BPC-157TFSTFS-{CAT}-8964Medutest2025-Q399.934.48—Buyer-sourced0PASS
AX-2025-018633TirzepatideQSCQSC-2502-P5432Medutest2025-Q398.652.85106.2Buyer-sourced0PASS
AX-2025-018623RetatrutideQSCQSC-2502-D5359Janoshik2025-Q397.946.7595.3Buyer-sourced0PASS
AX-2025-021124RetatrutideSIGSIG-2508-6037PeptideMeter2025-Q396.292.55—Buyer-sourced0FAIL
AX-2025-020895Enclomiphene citrateWXTWXT-2506-V2798VendorInvestigate2025-Q399.214.50106.2Buyer-sourced1FAIL
AX-2025-020235RetatrutideGGPepsGGPE-2508-E1731Nordanalyt2025-Q397.692.6396.3Buyer-sourced0PASS
AX-2025-020162CJC-1295 with DACERPERP-2506-E9178Janoshik2025-Q399.224.55102.4Buyer-sourced0PASS
AX-2025-019934SemaglutideHJHJ-2507-Y6433Medutest2025-Q398.333.5792.0Buyer-sourced0PASS
AX-2025-019304RetatrutideAMBAMB-2502-A6319Janoshik2025-Q398.674.3191.8Buyer-sourced0PASS
AX-2025-018946RetatrutideASYASY-{CAT}-1860Janoshik2025-Q397.855.80100.0Laboratory-retained0PASS
AX-2025-018944RetatrutideASYASY-{CAT}-1860PeptideMeter2025-Q397.935.84—Buyer-sourced0PASS
AX-2025-020707Thymosin α1SGNSGN-2504-P9129PeptideMeter2025-Q399.595.54—Buyer-sourced0PASS